Cell culture media, also known as nutrient growth substances, are necessary for the growth and survival of cell cultures. The type of media used for cell development depends on the cell type. The cell media plays an important role in culturing cells used for various applications such as monoclonal antibody production, vaccine production, therapeutic protein production, cell and gene therapy, and drug screening and development, among others.
Meticulous Research®, in its latest publication on the Cell Culture Media Market, states that this market is expected to reach $14.64 billion by 2029, at a CAGR of 13.2% from 2022 to 2029.
The growth of this market is driven by factors such as growing demand for monoclonal bodies, increasing prevalence of chronic diseases, rising funding for cell-based research, growing demand for biopharmaceuticals, and increasing R&D spending in the life science sector. Furthermore, the growing adoption of 3D cell culture, the growth potential of personalized medicine, and emerging economies are expected to provide significant opportunities for the growth of this market. However, ethical concerns regarding cell biology research and reproducibility of results challenge the growth of the market upto a certain extent.
Download Free Report Sample Now : https://www.meticulousresearch.com/download-sample-report/cp_id=5318
To provide efficient analysis, Meticulous Research® has segmented this market based on product (serum-free media, chemically defined media, classical media, animal component-free, and other cell culture media), application [bioproduction (monoclonal antibody production, therapeutic protein production, vaccine production, and cell & gene therapy)], diagnostics, cancer research, drug screening & development, and stem cell research), end user (pharmaceutical & biotechnology companies, academic & research institutes, and diagnostic laboratories) and geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).
Based on product, in 2022, the serum-free media segment is estimated to account for the largest share of the cell culture media market. The major contributing factor for the large share is the use of cell culture techniques in companies and research institutes, hence the need for media to grow cells. Some of the major benefits offered by this media include consistent performance, increased growth and/or productivity, better control over physiological responsiveness, and reduced risk of contamination by serum-borne adventitious agents in cell culture. Several serum-free media have been developed and are generally formulated to support the culture of a single cell type.
Based on application, in 2022, the bioproduction segment is estimated to account for the largest share of the cell culture media market. Factors such as growing demand for biopharmaceutical products such as monoclonal antibodies, vaccines, and therapeutic proteins and growing demand for cell and gene therapies contributed to the large share. Additionally, during the pandemic, the surge for cell-based vaccines led to the growth of vaccine-specific cell culture media.
Speak to Analyst : https://www.meticulousresearch.com/speak-to-analyst/cp_id=5318
Based on end user, in 2022, the pharmaceutical & biotechnology companies segment is estimated to account for the largest share of the cell culture media market. The major factor contributing to the growth of this segment is the growing R&D spending of these companies for drug discovery & development, vaccine production, and research on cancer cells. These companies also used cell culture products to produce biomolecules, contributing to the largest share.
Based on geography, in 2022, North America is estimated to account for the largest share of the cell culture media market, followed by Europe and Asia-Pacific. There is growing recognition for outsourcing pharmaceuticals & biopharmaceuticals companies in the region. Also, the growing geriatric population coupled with the rising prevalence of chronic diseases has generated interest in studies to find new drugs against chronic diseases. Some of the other factors driving the growth of this regional segment include the growing regulatory approvals for cell culture-based vaccines, growth in the biotechnology & pharmaceutical industries, higher investments in cell-based research, and strong government support.
The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, and geographical presence of some of the key players in this market, such as Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), PromoCell GmbH (Germany), Cytiva (U.S.), Lonza Group Ltd (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Miltenyi Biotec B.V. & Co. KG (Germany), BioLogos (U.S.), STEMCELL Technologies Inc. (Canada), and Cell Applications, Inc. (U.S.).
Quick Buy Now: https://www.meticulousresearch.com/Checkout/87099746
Key questions answered in the report-
- Which are the high-growth market segments in terms of product, application, end user, and region/country?
- What was the historical market for cell culture media across the globe?
- What are the market forecasts and estimates for the period 2022–2029?
- What are the major drivers, restraints, opportunities, and challenges in the cell culture media market?
- Who are the major players in the cell culture media market?
- What is the competitive landscape, and who are the market leaders in the cell culture media market?
- What are the recent developments in the cell culture media market?
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research